Anthera Pharmaceuticals Stock Number Of Employees
Anthera Pharmaceuticals fundamentals help investors to digest information that contributes to Anthera Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Anthera Pink Sheet. The fundamental analysis module provides a way to measure Anthera Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anthera Pharmaceuticals pink sheet.
Anthera |
Anthera Pharmaceuticals Company Number Of Employees Analysis
Anthera Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Anthera Pharmaceuticals Number Of Employees | 21 |
Most of Anthera Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anthera Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Anthera Pharmaceuticals is currently employing 21.0 people. This is 99.81% lower than that of the Biotechnology sector and 96.08% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.89% higher than that of the company.
Anthera Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anthera Pharmaceuticals' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Anthera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Anthera Pharmaceuticals by comparing valuation metrics of similar companies.Anthera Pharmaceuticals is currently under evaluation in number of employees category among its peers.
Anthera Fundamentals
Return On Equity | -5.69 | ||||
Return On Asset | -1.42 | ||||
Current Valuation | (7.47 M) | ||||
Shares Outstanding | 26.18 M | ||||
Number Of Shares Shorted | 2.02 M | ||||
Price To Earning | (0.20) X | ||||
Price To Book | 0.11 X | ||||
Gross Profit | (28.49 M) | ||||
EBITDA | (26.59 M) | ||||
Net Income | (26.87 M) | ||||
Cash And Equivalents | 8.09 M | ||||
Cash Per Share | 0.31 X | ||||
Debt To Equity | 1.61 % | ||||
Current Ratio | 3.30 X | ||||
Book Value Per Share | 0.21 X | ||||
Cash Flow From Operations | (36.9 M) | ||||
Short Ratio | 2.09 X | ||||
Earnings Per Share | (1.76) X | ||||
Price To Earnings To Growth | (0.05) X | ||||
Target Price | 3.0 | ||||
Number Of Employees | 21 | ||||
Beta | -108.04 | ||||
Market Capitalization | 617.83 K | ||||
Total Asset | 3.67 M | ||||
Retained Earnings | (436.8 M) | ||||
Working Capital | 39.39 M | ||||
Current Asset | 47.86 M | ||||
Current Liabilities | 8.47 M | ||||
Net Asset | 3.67 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |